1build Announces $19.5M in Funding
25 Sep, 2021
– Triad Life Sciences, a Memphis, Tenn.-based biotech company, raised AUS$25m funding round.
– The convertible note placement was led by Cannacord Genuity.
– The company intends to use the funds for its US sales force expansion plans, R&D activities, and general working capital needs.